Patexia Research

Case number 1:21-cv-00875

Lawsuits

AstraZeneca AB et al v. Alembic Pharmaceuticals Ltd. et al > Summary

Court Case Number 1:21-cv-00875

Filing Date Jun 18, 2021

Termination Date Dec 30, 2022

Court Delaware District Court

Status Judgment - Judgment on Consent

JudgesRichard G. Andrews

Plaintiff

Defendant

2

Alembic Pharmaceuticals, Inc.

Alembic Pharmaceuticals Ltd.

Plaintiff Attorneys

5

AstraZeneca
Attorney Name: Alexandra M. Joyce
McCarter & English

AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English

AstraZeneca
Attorney Name: Ryan P. O'Quinn
Finnegan, Henderson, Farabow, Garrett & Dunner

AstraZeneca
Attorney Name: Mark J. Feldstein
Finnegan, Henderson, Farabow, Garrett & Dunner

Attorney Name: Michael P. Kelly

Defendant Attorneys

4

Alembic Pharmaceuticals Ltd.
Attorney Name: April M. Ferraro
Abrams & Bayliss LLP

Alembic Pharmaceuticals Ltd.
Attorney Name: John M. Seaman
Abrams & Bayliss LLP

Alembic Pharmaceuticals, Inc.
Attorney Name: April M. Ferraro
Abrams & Bayliss LLP

Alembic Pharmaceuticals, Inc.
Attorney Name: John M. Seaman
Abrams & Bayliss LLP

Counter Defendant

26

AstraZeneca
Attorney Name: Alexandra M. Joyce
McCarter & English

AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English

AstraZeneca
Attorney Name: Alexandra M. Joyce
McCarter & English

AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English

AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English

AstraZeneca
Attorney Name: Alexandra M. Joyce
McCarter & English

AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English

AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English

AstraZeneca
Attorney Name: Alexandra M. Joyce
McCarter & English

AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English

AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English

AstraZeneca
Attorney Name: Alexandra M. Joyce
McCarter & English

AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English

AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English

AstraZeneca
Attorney Name: Alexandra M. Joyce
McCarter & English

AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English

AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English

AstraZeneca
Attorney Name: Alexandra M. Joyce
McCarter & English

AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English

AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English

AstraZeneca
Attorney Name: Alexandra M. Joyce
McCarter & English

AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English

AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English

AstraZeneca
Attorney Name: Alexandra M. Joyce
McCarter & English

AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English

AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English

Counter Claimant

8

Alembic Pharmaceuticals, Inc.
Attorney Name: April M. Ferraro
Abrams & Bayliss LLP

Alembic Pharmaceuticals, Inc.
Attorney Name: John M. Seaman
Abrams & Bayliss LLP

Alembic Pharmaceuticals Ltd.
Attorney Name: April M. Ferraro
Abrams & Bayliss LLP

Alembic Pharmaceuticals Ltd.
Attorney Name: John M. Seaman
Abrams & Bayliss LLP

Alembic Pharmaceuticals Ltd.
Attorney Name: April M. Ferraro
Abrams & Bayliss LLP

Alembic Pharmaceuticals Ltd.
Attorney Name: April M. Ferraro
Abrams & Bayliss LLP

Alembic Pharmaceuticals Ltd.
Attorney Name: April M. Ferraro
Abrams & Bayliss LLP

Alembic Pharmaceuticals Ltd.
Attorney Name: April M. Ferraro
Abrams & Bayliss LLP

Cause

35:271 Patent Infringement

Related Patents

Doc No	Title	Issue date
10300065	Method of treating or prevention of atherothrombotic events in patients with history of myocardial infarction	May 28, 2019
08425934	Pharmaceutical compositions	Apr 23, 2013